Atlas Trials

Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy

Clinical trial NCT02354781 · COMPLETED

Trial details

NCT number
NCT02354781
Sponsor
Jerry R. Mendell
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2015-01-01
Primary completion
2017-11-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.